Skip to main content
INVA logo

Innoviva, Inc.

INVANASDAQHealthcareBiotechnology

$20.66Today:- (-)1Y +15.33%

As of Oct 23, 2026 close

Market cap
$1.52B
P/E (TTM)
4.25
Forward P/E
2.42
Dividend yield
-
52-week range
$17.13$25.15
Volume (live)
-
Avg. volume (3M)
895.89K

Innoviva (INVA) Income Statement

Innoviva reported revenue of $411.33M in fiscal 2025 (fiscal year ended Dec 31, 2025), up 14.7% from $358.71M a year earlier. Net income was $271.17M, up 1059.2% year over year, a net margin of 65.9%. Gross margin was 81.2% and operating margin 39.8%. In the most recent quarter, Q2 fiscal 2026 (ended Jun 30, 2026), revenue was $119.59M, up 19.3% from the same quarter a year earlier.

Innoviva Income Statement Analysis

Values in millions USD

Scroll to see more
Innoviva, Inc. income statement - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Revenue & Gross Profit
Revenue411.33358.71310.46331.34391.87336.79261.02261.00217.22
Cost of Revenue77.3836.6042.6413.790.580.000.000.001.36
Gross Profit333.94322.11267.82317.55391.87336.79261.02261.00215.86
Operating Expenses
Research & Development30.6013.6533.9241.430.581.790.000.001.36
Selling, General & Administrative113.32115.6998.2363.5416.1913.8814.6617.0532.26
Operating Expenses170.20155.25153.94110.5516.7615.6714.6622.7532.26
Operating Income163.75166.87113.89207.00375.10321.12246.36238.25183.60
Other Income/Expense
Interest Income21.0919.1415.826.371.841.525.541.661.31
Interest Expense16.7022.2119.1615.79-19.0718.3318.6623.9543.60
Other Income/Expense158.73-126.4180.2189.37-111.8933.12-13.47-28.00-49.33
Income
Income Before Tax326.8637.39194.10286.95445.28354.25232.90210.26134.27
Income Tax Expense55.7014.0014.3866.6976.4460.4341.90-196.070.00
Net Income271.1723.39179.72213.92265.85224.40157.29395.06134.14
Net Income - Continuous Operations271.1723.39179.72220.26368.84224.40157.29395.06134.14
Net Income - Discontinued Operations---------
EBITDA369.8485.50235.04308.32375.11372.58260.23248.08205.69
EBIT343.5659.60213.26302.74375.10322.82---
Depreciation & Amortization26.2825.9021.785.580.010.0013.8713.8713.98
Earnings Per Share
Basic EPS4.00-3.003.003.002.002.004.001.00
Diluted EPS3.00-2.002.003.002.001.004.001.00
Basic Shares Outstanding67.4062.7365.4469.6482.06101.32101.15100.85106.95
Diluted Shares Outstanding84.7674.1986.8895.2594.31113.55113.41113.41119.87

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Innoviva Financial Statements

What was Innoviva's revenue in fiscal 2025?

Innoviva reported revenue of $411.33M in fiscal 2025 (fiscal year ended Dec 31, 2025). That was up 14.7% from $358.71M a year earlier.

Is Innoviva profitable?

Yes. Innoviva earned net income of $271.17M in fiscal 2025, a net margin of 65.9%. In fiscal 2024 it earned $23.39M.

What is Innoviva's operating margin?

Innoviva's operating income was $163.75M on revenue of $411.33M in fiscal 2025, an operating margin of 39.8%, compared with 46.5% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition